It is sometimes difficult to be inspired when trying to write a persuasive essay, book report or thoughtful research paper. Often of times, it is hard to find words that best describe your ideas.
VIPessays now provides a database of over 150,000 quotations and proverbs from the famous inventors, philosophers, sportsmen, artists, celebrities, business people, and authors that are aimed to enrich and strengthen your essay, term paper, book report, thesis or research paper.
Try our free search of constantly updated quotations and proverbs database.
Letter "P" » Paul Donovan Quotes
«If successful, we would combine the resources of two of the leading innovators in cardiovascular medicine and would expand our footprint into cardiac rhythm management. The Guidant acquisition is a natural outgrowth of our strategy to further diversify our business and accelerate growth.»
«We believe this issue has no bearing on our proposed acquisition of Guidant. Unfortunately, threats of legal action are commonplace in our industry.»
«We factored in the possibility of something like this happening. This news is manageable and does not alter our fundamental belief in Guidant's long-term potential, which is significant and very much intact.»
«We believe we can close by the end of March.»
«It's clear we have not done enough to resolve the issues raised by the FDA, and we recognize fully that the responsibility to do so lies with us.»
«We should have things re-stocked in a few weeks.»
«We've reviewed the intellectual property issues and are comfortable proceeding with the transaction. We don't expect this issue to impact the transaction.»
«The issues that we addressed in our commitments were not material ones. At the request of the commission we made a number of commitments in order to resolve potential antitrust issues, as did Abbott.»
«The Easter holiday in Europe pushes the due date back a few days, but we still believe the Commission may conclude its review before that date, and our goal is still to close during the first week of April.»
«We will recommend changes designed to ensure that the final regulation preserves the fullest possible beneficiary access to innovative technologies and therapies.»